Triple Agonist

$400.00

Purchase & earn 200 points!
-
+

The “Triple Agonist” Mechanism

While Tir-2  targets GLP-1 and GIP, Ret-3 adds a third hormone: Glucagon.

  • GLP-1: Reduces appetite and slows digestion.
  • GIP: Improves insulin secretion and fat metabolism.
  • Glucagon: Increases energy expenditure (calorie burning) and specifically targets the breakdown of fat in the liver.

Key Health Benefits & Reports (2026 Data)

Factor

Reported Results (Phase 3 Data)

Weight Loss

24% to 29% average body weight loss. Destroys white visceral fat, “the silent killer”.

Blood Sugar (A1C)

Reductions of 1.7% to 2.0% in Type 2 diabetics, potentially outperforming current “gold standard” medications.

Liver Fat

Unprecedented 82% to 86% reduction in liver fat. Nearly 90% of patients achieved “normal” liver fat levels.

Joint Health

75.8% reduction in pain scores for patients with knee osteoarthritis, likely due to the massive reduction in mechanical load and inflammation.

Metabolic Rate

Unlike previous peptides, the glucagon component helps prevent the metabolic slowdown typically seen during aggressive weight loss.

 

Related products

Advanced Peptide Research


All products sold by APR Labs are for laboratory research use only. Not for human or animal consumption, injection, or medical use. APR Labs does not provide medical advice. By purchasing, you agree that you are a qualified professional and assume all responsibility for handling and use. See our Research Use Disclaimer for full terms.

You must be
21+ years old to access this website.

By clicking ENTER, you confirm that you are 21 or older and understand that all products sold by APR Labs are strictly for research purposes only and NOT for human or animal consumption, or for any medical or therapeutic use.You also agree to comply with all applicable laws and take full responsibility for proper handling and use.

If you do not agree, please click EXIT.